2024
Living in disadvantaged neighborhoods linked to less intervention for severe aortic stenosis
Ram C, Yousef S, Ma W, Vallabhajosyula I, Singh S, Agarwal R, Milewski R, Assi R, Patel P, Williams M, Geirsson A, Vallabhajosyula P. Living in disadvantaged neighborhoods linked to less intervention for severe aortic stenosis. Scientific Reports 2024, 14: 4952. PMID: 38418864, PMCID: PMC10902341, DOI: 10.1038/s41598-024-52660-w.Peer-Reviewed Original ResearchConceptsAortic valve replacementSevere aortic stenosisAfrican American raceArea Deprivation IndexAortic stenosisSevere ASArea deprivation index rankAortic valve replacement ratesAmerican raceAortic valve interventionPresentation of sepsisDiagnosis of ASADI groupValve replacementValve interventionDeprived neighbourhoodsAV interventionDisadvantaged neighborhoodsPatientsFemale genderDeprivation indexHigh-ADI groupLow-ADI groupStenosisRace
2023
Exeporfinium chloride (XF-73) nasal gel dosed over 24 hours prior to surgery significantly reduced Staphylococcus aureus nasal carriage in cardiac surgery patients: Safety and efficacy results from a randomized placebo-controlled phase 2 study
Mangino J, Firstenberg M, Milewski R, Rhys-Williams W, Lees J, Dane A, Love W, Moreno J. Exeporfinium chloride (XF-73) nasal gel dosed over 24 hours prior to surgery significantly reduced Staphylococcus aureus nasal carriage in cardiac surgery patients: Safety and efficacy results from a randomized placebo-controlled phase 2 study. Infection Control And Hospital Epidemiology 2023, 44: 1171-1173. PMID: 36951472, PMCID: PMC10369221, DOI: 10.1017/ice.2023.17.Peer-Reviewed Original Research
2017
Peripheral Blood Gene Expression Changes Associated With Primary Graft Dysfunction After Lung Transplantation
Diamond J, Cantu E, Porteous M, Suzuki Y, Meyer K, Lederer D, Milewski R, Arcasoy S, D'Ovidio F, Bacchetta M, Sonett J, Singh G, Costa J, Tobias J, Rodriguez H, Van Deerlin V, Olthoff K, Shaked A, Chang B, Christie J, Investigators T. Peripheral Blood Gene Expression Changes Associated With Primary Graft Dysfunction After Lung Transplantation. American Journal Of Transplantation 2017, 17: 1770-1777. PMID: 28117940, PMCID: PMC5489369, DOI: 10.1111/ajt.14209.Peer-Reviewed Original ResearchConceptsPrimary graft dysfunctionGraft dysfunctionLung transplantationPeripheral blood gene expressionFirst transplant yearImmune regulation genesInflammasome-related proteinsDays of transplantBlood of patientsAdaptive immunity genesBlood gene expressionAllograft reperfusionTransplant yearClinical trialsPGD developmentGrade 3T cellsTransplantGene expressionHypothesis-driven genesRNA expressionGene expression changesReperfusionAllograftsPatients
2013
137TRANSCATHETER AORTIC VALVE IMPLANTATION IN PATIENTS WITH ASCENDING AORTIC DILATATION: SAFETY OF THE PROCEDURE AND MID-TERM FOLLOW-UP OF 100 PATIENTS
Rylski B, Szeto W, Bavaria J, Walsh E, Anwaruddin S, Desai N, Herrmann H, Milewski R. 137TRANSCATHETER AORTIC VALVE IMPLANTATION IN PATIENTS WITH ASCENDING AORTIC DILATATION: SAFETY OF THE PROCEDURE AND MID-TERM FOLLOW-UP OF 100 PATIENTS. Interdisciplinary CardioVascular And Thoracic Surgery 2013, 17: s102-s103. DOI: 10.1093/icvts/ivt372.137.Peer-Reviewed Original ResearchTranscatheter aortic valve implantationAortic valve implantationAortic dilatationAortic diameterValve implantationSafety of TAVIAdverse aortic eventsAscending Aortic DilatationFourth of patientsModerate aortic dilatationSevere aortic stenosisOne-year survivalAscending aortic diameterHospital mortalityAortic eventsAortic interventionIatrogenic dissectionAortic ruptureAortic stenosisHeart failureModerate dilatationInclusion criteriaPatientsDilatationAorta